MedTrace Logo

Acquiring Convalescent Specimens for COVID-19 Antibodies

NCT04342195 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2022-07-20

No results posted yet for this study

Summary

Blood samples from participants who have recovered from COVID-19 infection will be obtained and studied. The goal of the research is to identify antibodies that have been generated by the patient to fight the COVID-19 infection. By identifying the most effective antibodies, scientists can make specific antibodies to use to prevent future coronavirus outbreaks or to treat patients with severe disease.

Conditions

  • COVID-19
  • Coronavirus Infection
  • Corona Virus Infection

Interventions

PROCEDURE

Blood draw

Participants will have approximately 45 ml of whole blood drawn (3 Tablespoons) drawn at the study visit.

Sponsors & Collaborators

Principal Investigators

  • David Ho, M.D, · Columbia University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-25
Primary Completion
2021-03-12
Completion
2021-03-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04342195 on ClinicalTrials.gov